These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 11974672)

  • 1. The Framingham Study: historical insight on the impact of cardiovascular risk factors in men versus women.
    Kannel WB
    J Gend Specif Med; 2002; 5(2):27-37. PubMed ID: 11974672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors that attenuate the female coronary disease advantage.
    Kannel WB; Wilson PW
    Arch Intern Med; 1995 Jan; 155(1):57-61. PubMed ID: 7802521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Established cardiovascular disease and CVD risk factors in a primary care population of middle-aged Irish men and women.
    Creagh D; Neilson S; Collins A; Colwell N; Hinchion R; Drew C; O'Halloran D; Perry IJ
    Ir Med J; 2002; 95(10):298-301. PubMed ID: 12542011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study.
    Levitzky YS; Pencina MJ; D'Agostino RB; Meigs JB; Murabito JM; Vasan RS; Fox CS
    J Am Coll Cardiol; 2008 Jan; 51(3):264-70. PubMed ID: 18206734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sudden coronary death in women.
    Kannel WB; Wilson PW; D'Agostino RB; Cobb J
    Am Heart J; 1998 Aug; 136(2):205-12. PubMed ID: 9704680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Waist circumference predicts cardiometabolic and global Framingham risk among women screened during National Woman's Heart Day.
    Mosca L; Edelman D; Mochari H; Christian AH; Paultre F; Pollin I
    J Womens Health (Larchmt); 2006; 15(1):24-34. PubMed ID: 16417415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing cardiovascular disease burden due to diabetes mellitus: the Framingham Heart Study.
    Fox CS; Coady S; Sorlie PD; D'Agostino RB; Pencina MJ; Vasan RS; Meigs JB; Levy D; Savage PJ
    Circulation; 2007 Mar; 115(12):1544-50. PubMed ID: 17353438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex-specific cardiovascular morbidity and mortality in a cohort treated for hypertension.
    Li C; Engström G; Hedblad B; Janzon L
    J Hypertens; 2006 Aug; 24(8):1523-9. PubMed ID: 16877954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of cardiovascular risk factors in an urban sample of Portuguese adults according to the Framingham risk prediction models.
    Friões F; Azevedo A; Castro A; Alvelos M; Pimenta J; Vazquez B; Bettencourt P; Barros H
    Rev Port Cardiol; 2003 Apr; 22(4):511-20. PubMed ID: 12879643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age.
    Lloyd-Jones DM; Leip EP; Larson MG; D'Agostino RB; Beiser A; Wilson PW; Wolf PA; Levy D
    Circulation; 2006 Feb; 113(6):791-8. PubMed ID: 16461820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in CHD and risk factors at age 55-64 in the Framingham Study.
    D'Agostino RB; Kannel WB; Belanger AJ; Sytkowski PA
    Int J Epidemiol; 1989; 18(3 Suppl 1):S67-72. PubMed ID: 2807709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: the cardiovascular health study.
    Cushman M; Arnold AM; Psaty BM; Manolio TA; Kuller LH; Burke GL; Polak JF; Tracy RP
    Circulation; 2005 Jul; 112(1):25-31. PubMed ID: 15983251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-reactive protein and risk of cardiovascular disease in men and women from the Framingham Heart Study.
    Wilson PW; Nam BH; Pencina M; D'Agostino RB; Benjamin EJ; O'Donnell CJ
    Arch Intern Med; 2005 Nov; 165(21):2473-8. PubMed ID: 16314543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Women in Pakistan have a greater burden of clinical cardiovascular risk factors than men.
    Jafar TH
    Int J Cardiol; 2006 Jan; 106(3):348-54. PubMed ID: 16337043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Undertreatment and overtreatment with statins: the Oslo Health Study 2000-2001.
    Tonstad S; Rosvold EO; Furu K; Skurtveit S
    J Intern Med; 2004 Apr; 255(4):494-502. PubMed ID: 15049884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex differences in risk for coronary heart disease mortality associated with diabetes and established coronary heart disease.
    Natarajan S; Liao Y; Cao G; Lipsitz SR; McGee DL
    Arch Intern Med; 2003 Jul; 163(14):1735-40. PubMed ID: 12885690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
    Whitfield MD; Gillett M; Holmes M; Ogden E
    Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of exercise testing in the prediction of coronary disease risk among asymptomatic persons as a function of the Framingham risk score.
    Balady GJ; Larson MG; Vasan RS; Leip EP; O'Donnell CJ; Levy D
    Circulation; 2004 Oct; 110(14):1920-5. PubMed ID: 15451778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is cardiovascular disease in women inevitable?: preparing for menopause and beyond.
    Johannes J; Bairey Merz CN
    Cardiol Rev; 2011; 19(2):76-80. PubMed ID: 21285667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive accuracy of the 'Framingham's general CVD algorithm' in a Middle Eastern population: Tehran Lipid and Glucose Study.
    Bozorgmanesh M; Hadaegh F; Azizi F
    Int J Clin Pract; 2011 Mar; 65(3):264-73. PubMed ID: 21314863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.